Author details

Full Name

David G Camp

Affiliation

ORCID

Career Start Year

1988

Papers

162

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
29116567	LC-SRM-Based Targeted Quantification of Urinary Protein Biomarkers.	Methods Mol Biol	2018
28810879	Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics.	J Transl Med	2017
26700264	Quantitative Profiling of Protein S-Glutathionylation Reveals Redox-Dependent Regulation of Macrophage Function during Nanoparticle-Induced Oxidative Stress.	ACS Nano	2016
27165815	Mining the human urine proteome for monitoring renal transplant injury.	Kidney Int	2016
26581546	The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification.	Expert Rev Proteomics	2016
26151086	Compensatory Islet Response to Insulin Resistance Revealed by Quantitative Proteomics.	J Proteome Res	2015
25593928	Perturbations in the urinary exosome in transplant rejection.	Front Med (Lausanne)	2015
25517423	Sensitive targeted quantification of ERK phosphorylation dynamics and stoichiometry in human cells without affinity enrichment.	Anal Chem	2015
25889691	Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods.	J Transl Med	2015
24555535	LC-MS proteomics analysis of the insulin/IGF-1-deficient Caenorhabditis elegans daf-2(e1370) mutant reveals extensive restructuring of intermediary metabolism.	J Proteome Res	2014
25412208	HAM-5 functions as a MAP kinase scaffold during cell fusion in Neurospora crassa.	PLoS Genet	2014
25411699	Proteomic approaches for site-specific O-GlcNAcylation analysis.	Bioanalysis	2014
25266362	Antibody-independent targeted quantification of TMPRSS2-ERG fusion protein products in prostate cancer.	Mol Oncol	2014
24251762	A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serum.	J Proteome Res	2014
24336471	Resin-assisted enrichment of thiols as a general strategy for proteomic profiling of cysteine-based reversible modifications.	Nat Protoc	2014
24335474	The identification of novel potential injury mechanisms and candidate biomarkers in renal allograft rejection by quantitative proteomics.	Mol Cell Proteomics	2014
24333276	Proteomic identification and quantification of S-glutathionylation in mouse macrophages using resin-assisted enrichment and isobaric labeling.	Free Radic Biol Med	2014
24277029	Phosphate-containing polyethylene glycol polymers prevent lethal sepsis by multidrug-resistant pathogens.	Antimicrob Agents Chemother	2014
24586154	Metabolic reprogramming during purine stress in the protozoan pathogen Leishmania donovani.	PLoS Pathog	2014
25145539	Expediting SRM assay development for large-scale targeted proteomics experiments.	J Proteome Res	2014
25118826	Polysialylated N-glycans identified in human serum through combined developments in sample preparation, separations, and electrospray ionization-mass spectrometry.	Anal Chem	2014
24568099	Optimization for peptide sample preparation for urine peptidomics.	Clinical Proteomics	2014
24928210	Detecting differential protein expression in large-scale population proteomics.	Bioinformatics	2014
24881670	GlyQ-IQ: glycomics quintavariate-informed quantification with high-performance computing and GlycoGrid 4D visualization.	Anal Chem	2014
24881580	The proteome and phosphoproteome of Neurospora crassa in response to cellulose, sucrose and carbon starvation.	Fungal Genet Biol	2014
24691437	Cytomegalovirus pp65 limits dissemination but is dispensable for persistence.	J Clin Invest	2014
23495885	Sources of technical variability in quantitative LC-MS proteomics: human brain tissue sample analysis.	J Proteome Res	2013
24002365	Reduced insulin/insulin-like growth factor-1 signaling and dietary restriction inhibit translation but preserve muscle mass in Caenorhabditis elegans.	Mol Cell Proteomics	2013
23772796	Resin-assisted enrichment of N-terminal peptides for characterizing proteolytic processing.	Anal Chem	2013
24039694	Gray matter is targeted in first-attack multiple sclerosis.	PLoS One	2013
23763644	Targeted quantification of low ng/mL level proteins in human serum without immunoaffinity depletion.	J Proteome Res	2013
24004026	Long-gradient separations coupled with selected reaction monitoring for highly sensitive, large scale targeted protein quantification in a single analysis.	Anal Chem	2013
23277143	Quantitative site-specific reactivity profiling of S-nitrosylation in mouse skeletal muscle using cysteinyl peptide enrichment coupled with mass spectrometry.	Free Radic Biol Med	2013
23268687	In-source fragmentation and the sources of partially tryptic peptides in shotgun proteomics.	J Proteome Res	2013
23589343	Trauma-associated human neutrophil alterations revealed by comparative proteomics profiling.	Proteomics Clin Appl	2013
23303698	STEPS: a grid search methodology for optimized peptide identification filtering of MS/MS database search results.	Proteomics	2013
23507713	Determination of burn patient outcome by large-scale quantitative discovery proteomics.	Crit Care Med	2013
22136231	Mapping N-linked glycosylation sites in the secretome and whole cells of Aspergillus niger using hydrazide chemistry and mass spectrometry.	J Proteome Res	2012
22509832	Quantitative phosphoproteomics identifies filaggrin and other targets of ionizing radiation in a human skin model.	Exp Dermatol	2012
22846433	Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests.	J Proteomics	2012
22433316	The cerebrospinal fluid proteome in HIV infection: change associated with disease severity.	Clin Proteomics	2012
22339560	Simple sodium dodecyl sulfate-assisted sample preparation method for LC-MS-based proteomics applications.	Anal Chem	2012
22577010	Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics.	Proteomics	2012
22462785	High-pH reversed-phase chromatography with fraction concatenation for 2D proteomic analysis.	Expert Rev Proteomics	2012
22331615	Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus-mediated liver disease posttransplantation.	Hepatology	2012
22949669	Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum.	Proc Natl Acad Sci U S A	2012
22718821	Reevaluation of the coding potential and proteomic analysis of the BAC-derived rhesus cytomegalovirus strain 68-1.	J Virol	2012
22900834	Cerebrospinal fluid proteome of patients with acute Lyme disease.	J Proteome Res	2012
22559202	Label-free quantitative LC-MS proteomics of Alzheimer's disease and normally aged human brains.	J Proteome Res	2012
22517741	Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets.	Proc Natl Acad Sci U S A	2012